Metabolic Basis of Circadian Dysfunction in Parkinson’s Disease

• Published in: Biology (Basel, Switzerland) Switzerland), 2023-09, Vol.12 (10), p.1294
• Main Authors: Rathor, Priya, Ch, Ratnasekhar
• Format: Article
• Language: English
• Subjects: Amino acids; Animal models; Biomarkers; Body temperature; circadian dysfunction; Circadian rhythm; Circadian rhythms; Cognitive ability; Development and progression; Dopamine receptors; Energy metabolism; Enzymes; Gene expression; Health aspects; Homeostasis; Metabolism; Metabolites; Movement disorders; Neurodegenerative diseases; Neurons; Parkinson's disease; Pathogenesis; Physiological aspects; Physiology; Polyamines; Proteins; Quality of life; Review; Sleep; Sleep deprivation; Sleep disorders; Synuclein
• ISSN: 2079-7737; 2079-7737
• DOI: 10.3390/biology12101294

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The management of PD is a challenging aspect for general physicians and neurologists. It is characterized by the progressive loss of dopaminergic neurons. Impaired α-synuclein secretion and dopamine release may cause mitochondrial dysfunction and perturb energy metabolism, subsequently altering the activity and survival of dopaminergic neurons, thus perpetuating the neurodegenerative process in PD. While the etiology of PD remains multifactorial, emerging research indicates a crucial role of circadian dysfunction in its pathogenesis. Researchers have revealed that circadian dysfunction and sleep disorders are common among PD subjects and disruption of circadian rhythms can increase the risk of PD. Hence, understanding the findings of circadian biology from translational research in PD is important for reducing the risk of neurodegeneration and for improving the quality of life. In this review, we discuss the intricate relationship between circadian dysfunction in cellular metabolism and PD by summarizing the evidence from animal models and human studies. Understanding the metabolic basis of circadian dysfunction in PD may shed light on novel therapeutic approaches to restore circadian rhythm, preserve dopaminergic function, and ameliorate disease progression. Further investigation into the complex interplay between circadian rhythm and PD pathogenesis is essential for the development of targeted therapies and interventions to alleviate the burden of this debilitating neurodegenerative disorder.